- Home
- RNXT vs ACST Comparison
RNXT vs ACST Comparison
Compare RNXT & ACST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- ACST
- Stock Information
- Founded
- RNXT 2012
- ACST 2002
- Country
- RNXT United States
- ACST United States
- Employees
- RNXT N/A
- ACST N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- ACST Pharmaceuticals and Biotechnology
- Sector
- RNXT Health Care
- ACST Health Care
- Exchange
- RNXT Nasdaq
- ACST Nasdaq
- Market Cap
- RNXT 24.0M
- ACST 27.2M
- IPO Year
- RNXT 2021
- ACST N/A
- Fundamental
- Price
- RNXT $1.00
- ACST $3.28
- Analyst Decision
- RNXT Strong Buy
- ACST Strong Buy
- Analyst Count
- RNXT 3
- ACST 2
- Target Price
- RNXT $6.13
- ACST $10.00
- AVG Volume (30 Days)
- RNXT 43.8K
- ACST 23.2K
- Earning Date
- RNXT 11-12-2024
- ACST 11-11-2024
- Dividend Yield
- RNXT N/A
- ACST N/A
- EPS Growth
- RNXT N/A
- ACST N/A
- EPS
- RNXT N/A
- ACST N/A
- Revenue
- RNXT N/A
- ACST N/A
- Revenue This Year
- RNXT N/A
- ACST N/A
- Revenue Next Year
- RNXT N/A
- ACST N/A
- P/E Ratio
- RNXT N/A
- ACST N/A
- Revenue Growth
- RNXT N/A
- ACST N/A
- 52 Week Low
- RNXT $0.53
- ACST $1.98
- 52 Week High
- RNXT $2.35
- ACST $3.59
- Technical
- Relative Strength Index (RSI)
- RNXT 46.64
- ACST 60.89
- Support Level
- RNXT $0.98
- ACST $3.20
- Resistance Level
- RNXT $1.02
- ACST $3.44
- Average True Range (ATR)
- RNXT 0.05
- ACST 0.17
- MACD
- RNXT -0.00
- ACST 0.01
- Stochastic Oscillator
- RNXT 31.25
- ACST 70.08
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About ACST Acasti Pharma Inc.
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.